These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 22381900)

  • 21. AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy.
    Zekri A; Ghaffari SH; Ghanizadeh-Vesali S; Yaghmaie M; Salmaninejad A; Alimoghaddam K; Modarressi MH; Ghavamzadeh A
    Tumour Biol; 2015 Feb; 36(2):623-32. PubMed ID: 25277659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line.
    Kim JY; Kim CH; Stratford IJ; Patterson AV; Hendry JH
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):376-85. PubMed ID: 14751506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
    Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S
    Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of genes that confer tumor cell resistance to the aurora B kinase inhibitor, AZD1152.
    Guo J; Anderson MG; Tapang P; Palma JP; Rodriguez LE; Niquette A; Li J; Bouska JJ; Wang G; Semizarov D; Albert DH; Donawho CK; Glaser KB; Shah OJ
    Pharmacogenomics J; 2009 Apr; 9(2):90-102. PubMed ID: 19188929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).
    Zekri A; Mesbahi Y; Boustanipour E; Sadr Z; Ghaffari SH
    J Mol Neurosci; 2018 Aug; 65(4):444-455. PubMed ID: 30051358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.
    Ghanizadeh-Vesali S; Zekri A; Zaker F; Zaghal A; Yousefi M; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Ann Hematol; 2016 Jun; 95(7):1031-42. PubMed ID: 27091351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients.
    Vischioni B; Oudejans JJ; Vos W; Rodriguez JA; Giaccone G
    Mol Cancer Ther; 2006 Nov; 5(11):2905-13. PubMed ID: 17121938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progeny.
    Wiedemuth R; Klink B; Fujiwara M; Schröck E; Tatsuka M; Schackert G; Temme A
    Carcinogenesis; 2016 Oct; 37(10):993-1003. PubMed ID: 27515963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.
    Brognard J; Clark AS; Ni Y; Dennis PA
    Cancer Res; 2001 May; 61(10):3986-97. PubMed ID: 11358816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibitors of aurora kinases inhibit proliferation, reduce cell viability and impair cell cycle progression in papillary thyroid carcinoma cells.
    Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Fallahi P; Mian C; Barollo S; Catania A; Morrone S; Tartaglia F; Mascagni D; Coccaro C; Pepe M; Filippini A; D'Armiento M; Ulisse S
    J Biol Regul Homeost Agents; 2015; 29(4):793-803. PubMed ID: 26753639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines.
    Liu N; Wang YA; Sun Y; Ecsedy J; Sun J; Li X; Wang P
    Respir Res; 2019 Oct; 20(1):230. PubMed ID: 31647033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synergistic effect of dimethylamino benzoylphenylurea (NSC #639829) and X-irradiation on human lung carcinoma cell lines.
    Balcer-Kubiczek EK; Attarpour M; Edelman MJ
    Cancer Chemother Pharmacol; 2007 May; 59(6):781-7. PubMed ID: 16957930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.
    Tuccilli C; Baldini E; Prinzi N; Morrone S; Sorrenti S; Filippini A; Catania A; Alessandrini S; Rendina R; Coccaro C; D'Armiento M; Ulisse S
    Endocrine; 2016 May; 52(2):287-95. PubMed ID: 26215279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target.
    Hartsink-Segers SA; Zwaan CM; Exalto C; Luijendijk MW; Calvert VS; Petricoin EF; Evans WE; Reinhardt D; de Haas V; Hedtjärn M; Hansen BR; Koch T; Caron HN; Pieters R; Den Boer ML
    Leukemia; 2013 Mar; 27(3):560-8. PubMed ID: 22940834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of AZD1152, a selective Aurora B kinase inhibitor, on Burkitt's and Hodgkin's lymphomas.
    Mori N; Ishikawa C; Senba M; Kimura M; Okano Y
    Biochem Pharmacol; 2011 May; 81(9):1106-15. PubMed ID: 21371446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.
    Schütze C; Dörfler A; Eicheler W; Zips D; Hering S; Solca F; Baumann M; Krause M
    Strahlenther Onkol; 2007 May; 183(5):256-64. PubMed ID: 17497097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process.
    Lordier L; Chang Y; Jalil A; Aurade F; Garçon L; Lécluse Y; Larbret F; Kawashima T; Kitamura T; Larghero J; Debili N; Vainchenker W
    Blood; 2010 Sep; 116(13):2345-55. PubMed ID: 20548097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.
    Niermann KJ; Moretti L; Giacalone NJ; Sun Y; Schleicher SM; Kopsombut P; Mitchell LR; Kim KW; Lu B
    Radiat Res; 2011 Apr; 175(4):444-51. PubMed ID: 21222513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.